An Introduction of the Vaporized Therapy with Tea Herb Drink for Relieving Agitation due to Pulmonary Encephalopathy

Updata:01-01-1970

Source:
By:Jianbo Hong, Mi mi zhou, Weisheng He, Yue Chen

DOI: https://doi.org/10.30564/jgm.v3i2.3818

Abstract:
What methods would you choose apart from increasing sedatives for
agitation in an advanced patient with hypercapnic encephalopathy due
to AECOPD? This is a 94-year-old female who suffered from COPD for
over 30 years, occurred with an accelerated episode of cough, productive
sputum and a dropping down to 86% in SatO₂ due to a cold weather. A
diagnosis of pulmonary encephalopathy (PE) was made on the basis of the
subsequent agitation and delirium, and the sedatives, such as quatiepine
and haloperidol, had to be given for her mental excitation respectively, but
she still pulled out indwelling needle herself and refused to any infusion
therapy. As an alternative, a vaporized therapy integrated with tea herb
drinking had to be applied to relieving her agitation, being designed
as the vaporization of the inhaled oxygenation by means of high-flow
oxygenation device (HFOD), with an ampoule of ambroxol mixed into the
inhaler and simultaneous drinking of TCM tea herb for reducing sputum,
helping dissolve the mucoid bolts inside her terminal bronchioles when
being infected. We thought that a better efficacy would be achieved for
hypercapnic encephalopathy due to AECOPD if we concentrate on a good
ventilation of small airway through the vaporized therapy.
References:

[1]Gupta H, Alrohimi A, Nathuo N, et al. (2020) Posterior reversible encephalopathy syndrome due to chronic obstructive pulmonary disease. Canadian journal of neurological sciences, 47: 569-571. [2]Wang J, Cui Z, Liu S, et al.(2017) Early use of noninvasive techniques for clearing respiratory secretions during noninvasive positive-pressure ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease and hypercapnic encephalopathy: A prospective cohort study. Medicine, 96: e6371. [3]Paleari D, Rossi GA, Nicolini G, et al.(2011) Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood. Expert Opin Drug Discov, 6:1203-1214. [4]Abiba.(1978) Effects of sublingual administration of Ephedra herba aqueous extracts on respiratory resistance in dogs. Annu Rep Tohoku Coll Pharm, 25: 23- 25. [5]Wilcox N, Minton J.(2001) Role of antibody response in outcome of antibiotic associated diarrhea. Lancet, 357:158-159. [6] Clift C, Salisbury DM.(2017) Enhancing the role of vaccines in combatting antimicrobial resistance. Vaccine, 35: 6591-6593.

Tags: